母体使用安替比林治疗预防新生儿黄疸。
Prophylaxis of neonatal jaundice with maternal antipyrine treatment.
作者信息
Lewis P J, Friedman L A
出版信息
Lancet. 1979 Feb 10;1(8111):300-2. doi: 10.1016/s0140-6736(79)90709-8.
PMID:84951
Abstract
A randomised controlled trial of antipyrine (phenazone) in the prophylaxis of neonatal jaundice was completed in 48 women. Treatment of mothers from the 38th week of pregnancy reduced neonatal plasma-bilirubin concentrations on the 4th day after birth by an average of 44%. Prophylaxis of neonatal jaundice merits a wider trial.
摘要
对48名女性进行了一项关于安替比林（非那宗）预防新生儿黄疸的随机对照试验。从妊娠第38周开始对母亲进行治疗，可使新生儿出生后第4天的血浆胆红素浓度平均降低44%。新生儿黄疸的预防值得进行更广泛的试验。
Zotero 插件